FDA Drug Application (021473) for CIPRO XR by BAYER HLTHCARE

Back to FDA Applications sponsored by BAYER HLTHCARE

Application Number021473
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage212.6MG;EQ 287.5MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCIPRO XR
Active IngredientCIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE



Back to FDA Applications sponsored by BAYER HLTHCARE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.